Connect with us

Technology

Hyperscale Data Provides Update on Progress of Michigan AI Data Center; More Than $70 Million Invested in Alliance Cloud Services and the Michigan Facility

Published

on

Operations under Previously Announced MSA Expected to Begin in November 2026

LAS VEGAS, Sept. 17, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI”) data center company anchored by Bitcoin (“Hyperscale Data” or the “Company”), provided an update on the continued development of its Michigan AI data center (the “Michigan Facility”) operated by Alliance Cloud Services, LLC, an indirect wholly owned subsidiary of the Company (“ACS”).

As of September 15, 2026, Hyperscale Data has invested more than $70 million into ACS and the development of the Michigan Facility. This investment represents a substantial portion of the overall capital program required to prepare the Michigan Facility for the deployment of AI compute capacity to ACS’ customer, a California-based neocloud provider, pursuant to the previously announced master services agreement between such provider and ACS (“MSA”).

As part of this investment and development program, the Company has acquired a substantial amount of the equipment required to bring the contracted capacity online at the Michigan Facility. Hyperscale Data is currently working toward commencing operations under the MSA in November 2026, at which point the Company expects to begin generating revenue and cash flow from the MSA.

The MSA provides for an initial 20 megawatts (“MW”) of critical AI compute capacity and has an initial 10-year term with two five-year extension options. If the MSA continues for the entire 20-year term, the Company expects it to generate more than approximately $1.2 billion in revenue.

Additionally, the customer has the right to increase critical AI compute capacity up to a total of 52 MW, which, if fully exercised and maintained for the entire 20-year term, is expected to increase total contract revenue to more than $3.0 billion.

52 MW of critical AI compute capacity deployment would represent less than 20% of the Michigan Facility’s approximately 340 MW total potential capacity. Even following a full 52 MW deployment by the existing customer, approximately 270 MW of potential additional capacity would remain for future development and additional customer deployments, subject to obtaining the required power, infrastructure, financing and regulatory approvals.

“Our investment of more than $70 million in ACS and the Michigan campus is about execution,” stated Will Horne, Chief Executive Officer of Hyperscale Data. “This capital is part of the overall investment required to prepare the facility for our neocloud customer under the MSA, and we have now acquired a substantial amount of the equipment required for the planned deployment. We are working toward bringing the initial contracted capacity online beginning in November, when we expect to start generating revenue and cash flow under an agreement that could generate more than $3.0 billion in revenue over a 20-year term.”

“We believe the more than $70 million invested to date has created a substantial foundation for this transformation,” continued Mr. Horne. “Our immediate priority is getting our customer online, generating cash flow and successfully executing the initial deployment. From there, we intend to continue developing the campus and pursuing the significant amount of potential capacity that remains.”

The Company continues to evaluate the optimal long-term strategy for ACS and the Michigan Facility, including continued development, strategic partnerships, additional customer deployments, a potential separation or initial public offering of ACS, or a potential sale of the Michigan Facility if the Company believes such a transaction would maximize stockholder value.

Hyperscale Data expects to provide additional updates as material developments and deployment milestones are achieved.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data’s wholly owned subsidiaries, Ault Capital Group, Inc. (“ACG”), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the “Divestiture”) to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the “Series F Preferred Stock”) to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the “ACG Shares”). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at hyperscaledata.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyperscale-data-provides-update-on-progress-of-michigan-ai-data-center-more-than-70-million-invested-in-alliance-cloud-services-and-the-michigan-facility-302881334.html

SOURCE Hyperscale Data Inc.

Continue Reading

Technology

RIVANNA announces new CMS procedure code for computer-aided neuraxial guidance

Published

on

By

Effective October 1, 2026, ICD-10-PCS code XEZU3HC establishes the first dedicated national inpatient coding category for real-time ultrasound navigation with continuous needle tracking

CHARLOTTESVILLE, Va., Sept. 17, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

Before XEZU3HC, use of diagnostic ultrasound navigation during neuraxial anesthesia was not separately reportable in inpatient hospital coding. Facilities could report the underlying neuraxial anesthesia under existing codes, but the navigation itself left no trace in the record. The new code changes what that record can show: a standardized way to identify coded use and track adoption, and, when linked with clinical and operational data, a basis for evaluating outcomes.

Unintended dural puncture occurs in 0.5% to 1.5% of labor epidural placements (Van de Velde 2008; Choi 2003), and the United States has no dedicated mandatory national reporting system for it. The consequences are not always brief: in a prospective multicenter cohort study that enrolled 90 patients with accidental dural puncture and 180 matched controls, 58% of those who experienced accidental dural puncture still had persistent headache at 18 months, compared with 17% of controls (Niraj 2021).

Accuro® 3S brings ultrasound guidance into the placement itself. It is the first FDA-cleared, AI-enabled, real-time ultrasound guidance system purpose-built for neuraxial anesthesia. The system combines automated anatomical guidance through SpineNav-AI™, midline needle access through the patented Dual-Array™ probe’s central aperture, and real-time needle-tip tracking through SafeTrack™. CMS recognized the technology as procedurally distinct. Beginning October 1, XEZU3HC makes this form of guidance identifiable in inpatient data.

“Accuro 3S was developed to bring real-time guidance to neuraxial procedures,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “With XEZU3HC, that procedural shift will no longer be invisible in inpatient data. The code does not prove benefit; it gives hospitals a standardized way to identify use and, when linked with clinical data, evaluate outcomes.” 

CMS placed XEZU3HC in Section X, New Technology, under the newly created XEZ table. The code applies to a procedural category, not to a specific company or product, and does not by itself establish separate payment. What it establishes is identification: a standardized data structure that can support evaluation of the clinical and economic impact of computer-aided neuraxial guidance across institutions.

“Neuraxial procedures are still performed largely by feel, and the complications that follow have been difficult to see in national data,” said Delphine Le Roux, PhD, PMP, Senior Director, Market Access and Strategic Partnerships at RIVANNA. “That was the case we brought to CMS: real-time guidance changes the procedure enough that it needs its own identifier. Coding, evidence, and reimbursement follow a sequence, and this is the first step. Real-world data can then help evaluate the clinical and economic value of navigation and inform future payment discussions.” 

Beginning in the fourth quarter of 2026, RIVANNA plans to include XEZU3HC, where assigned by participating facilities, in its outcomes framework alongside procedural and workflow data.

About Accuro 3S

Accuro 3S is a portable, cart-based, point-of-care diagnostic ultrasound system featuring the patented Dual-Array probe, automated anatomical guidance through SpineNav-AI, and real-time needle-tip tracking through SafeTrack. Two transducer arrays flank a central aperture through which the needle can be introduced and advanced along the spinal midline within the ultrasound imaging plane. SpineNav-AI automatically identifies lumbar spinal landmarks and midline and measures depth to the epidural space in real time. When used with a compatible tracked needle, SafeTrack displays needle-tip location and trajectory relative to the ultrasound image in real time.

Accuro 3S extends the clinical foundation established by the flagship Accuro platform. In a randomized trial of 80 obese parturients undergoing elective cesarean delivery with combined spinal-epidural anesthesia, first-insertion success was 72.5% with Accuro and 40.0% with palpation (p=0.003; Ni 2021). The published evidence pertains to the flagship Accuro platform; Accuro 3S-specific outcomes will be tracked through RIVANNA’s outcomes framework.

About RIVANNA

RIVANNA is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform is designed to automate complex anatomical analysis at the point of care, support faster and more confident clinical decisions, reduce variability, and expand access to advanced capabilities. Its initial applications address interventional guidance and trauma triage, beginning with neuraxial procedures and musculoskeletal injury assessment. RIVANNA has established an FDA-cleared product portfolio and maintains a worldwide intellectual-property portfolio of more than 100 issued and pending patents. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility.

RIVANNA, Accuro, and the Rivanna Medical family of marks are registered and unregistered trademarks of Rivanna Medical, Inc. in the United States and other jurisdictions. All other trademarks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rivanna-announces-new-cms-procedure-code-for-computer-aided-neuraxial-guidance-302881131.html

SOURCE RIVANNA

Continue Reading

Technology

Loadsmart Launches AI Agents That Come With Freight Operators Behind Them

Published

on

By

For enterprise shippers, AI agents take over the repetitive tasks — emails, phone calls, manual data entry — with 100% resolution guaranteed by Loadsmart’s in-house freight experts.

CHICAGO, Sept. 17, 2026 /PRNewswire/ — Loadsmart AI launches a set of AI agents that execute freight work end to end inside the systems enterprise shippers already run. The agents come backed by the company’s own freight operators, who close out any task the agents don’t resolve.

Loadsmart AI is built to start small. A shipper picks one repetitive, high-volume workflow, sets the rules and guardrails the agents run under, and Loadsmart builds an agent against the systems the team already uses, with no migration, no new platform to adopt, and nothing that touches the freight decisions the team owns.

“Transportation teams have been asked to adopt technology the same way for twenty years: buy the platform, migrate the data, retrain the team, hope it sticks,” said Felipe Capella, Co-founder and Chief Executive Officer of Loadsmart. “We don’t think AI arrives that way. It arrives one task at a time, inside the systems you already run, doing work you can watch it do. We’re not selling a tool for your team to manage. We’re selling the outcome, resolved and under full monitoring.”

The agents take the tasks. The team keeps the freight.

Loadsmart AI agents take a task and complete it: collecting and filing a document, pulling status from a carrier, rebooking a dock appointment, retendering a failed load, updating a record in the TMS. Roughly 80 percent of what the agents touch is resolved without a person stepping in, and that share rises as the agents learn how a specific customer operates.

The remaining share never comes back to the shipper. Loadsmart’s freight experts work the exception itself – the one task the agent couldn’t close – and see it through to resolution. They work inside the task, not the account. Every decision about the freight stays with the shipper’s team.

“A workflow that’s 80 percent automated still lands the other 20 percent on somebody’s desk. That isn’t removing work, it’s moving it,” said Ron Ben Yosef, Chief Technology Officer of Loadsmart. “So our freight experts work the exception, not the account. They finish the task the agent couldn’t finish, and nothing beyond it. The shipper’s team never stops running its own freight; it just stops doing the same thing five hundred times a month.”

The agents available at launch cover document collection and filing, tracking and status updates, tender failures and retendering, proactive load audits, claims processing, and scheduling and rescheduling. Each runs under rules and guardrails the customer defines, and connects to existing systems over API, EDI, MCP, or whatever the shipper already has in place.

If it doesn’t resolve, you don’t pay for it

A shipper can describe any repetitive, high-volume workflow its team runs by hand, and Loadsmart will build an agent for it against their existing stack. Loadsmart AI is available now, starting with a free Proof of Concept on a single workflow. If the agent doesn’t do the work, the shipper doesn’t pay for it. The average Proof of Concept implementation is 60 days.

“The agent list isn’t a roadmap we’re asking customers to wait on, it’s an open set,” said Paul Rehmet, Vice President of Product Management at Loadsmart. “Because we’ve spent a decade building against shippers’ actual systems and running freight through them ourselves, a new agent for a workflow we’ve never seen before is a matter of weeks, not a product cycle. Tell us which task your team repeats the most, and we’ll build the agent for it.”

More detail on each agent is at loadsmart.com/ai.

About Loadsmart

Loadsmart offers one connected logistics platform spanning the complete freight lifecycle — Opendock for dock, yard, and gate scheduling; ShipperGuide for transportation management; and Loadsmart AI for agent-led execution — alongside the company’s transportation operations. That combination makes Loadsmart the only company in freight that sells both the AI and the operators who stand behind it. Learn more at loadsmart.com.

Felipe Capella, Co-founder and Chief Executive Officer of Loadsmart, (felipe@loadsmart.com)

View original content to download multimedia:https://www.prnewswire.com/news-releases/loadsmart-launches-ai-agents-that-come-with-freight-operators-behind-them-302880549.html

SOURCE Loadsmart

Continue Reading

Technology

XpertDox and Kai Shin Clinic Partner to Bring AI-Powered Autonomous Medical Coding to Minnesota Behavioral Health and Primary Care

Published

on

By

XpertDox brings AI medical coding to Kai Shin Clinic’s addiction medicine, mental health, and primary care services across Minnesota, with a focus on accuracy, explainability, and compliance.

SCOTTSDALE, Ariz., Sept. 17, 2026 /PRNewswire/ — XpertDox, an AI medical coding software solutions provider, has partnered with Kai Shin Clinic, a Minnesota-based outpatient provider specializing in addiction medicine, mental health, psychiatry, and primary care. The partnership brings XpertDox’s autonomous medical coding solution into Kai Shin’s operations, with a shared focus on coding accuracy, explainability, and compliance.

About Kai Shin Clinic

Founded in 2016 by Dr. Alana Sasaki, Kai Shin Clinic delivers integrated, whole-person care for individuals with co-occurring substance use and mental health disorders. Across multiple Minnesota locations, the clinic provides medication-assisted treatment, intensive outpatient programs, psychiatry, primary care, and in-house lab services.

AI-Powered Medical Coding for Behavioral Health

XpertCoding is XpertDox’s flagship AI-powered autonomous medical coding engine. It combines Symbolic AI, Neural Networks, and Ensemble Machine Learning with payor-specific guidelines to support accurate, consistent, and compliant medical coding. It helps reduce administrative burden, improve documentation quality, and support HCC/RAF capture for value-based care, relevant for behavioral health and primary care organizations serving risk-adjusted populations.

“Our patients come to us for whole-person care, and accurate, transparent coding is part of delivering that responsibly,” said Alana Sasaki, MD, Founder and CEO of Kai Shin Clinic. “XpertCoding lets our team stay focused on care while keeping documentation quality and compliance at the center.”

XpertCoding Business Intelligence Platform

XpertCoding is accompanied by its Business Intelligence platform, giving coding teams and executive leadership clear visibility on risk adjustment, quality metrics, and coding accuracy. The BI platform also features CXO analytics and validation portals to evaluate coded claims for review and benchmarking. Every coding decision can be traced back to the provider’s documentation, giving billing and compliance teams a clear, auditable record.

“We are proud to partner with Kai Shin Clinic and to support their mission of delivering accessible, whole-person care across Minnesota,” said Sameer Ather, CEO and Co-Founder of XpertDox. “Our goal with any provider is the same. We want autonomous medical coding to bring efficiency to the revenue cycle without asking anyone to give up transparency or control.”

Founded in 2015 and headquartered in Phoenix, Arizona, XpertDox provides AI-powered autonomous medical coding software and revenue cycle analytics. Its flagship product, XpertCoding, also offers medical coding AI with HCC/RAF risk adjustment support and quality metrics reporting for value-based care. XpertDox serves FQHCs, behavioral health, women’s care, primary care, orthopedic, pediatric care, dental, urgent care, multispecialty groups, health systems, and RCM organizations, with a focus on coding accuracy, regulatory compliance, and reduced administrative burden.

Visit www.xpertdox.com or contact marketing@xpertdox.com for more information.

Press Release Service provided by 24-7PressRelease.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/xpertdox-and-kai-shin-clinic-partner-to-bring-ai-powered-autonomous-medical-coding-to-minnesota-behavioral-health-and-primary-care-302881357.html

SOURCE XpertDox

Continue Reading

Trending